AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML).
暂无分享，去创建一个
P. Zarrinkar | Mazen W. Karaman | G. Pallares | H. Patel | M. Levis | K. Pratz | R. Armstrong | B. Belli | R. Gunawardane | Merryl D. Cramer | M. F. Gardner | D. Brigham | Q. Chao | K. Sprankle | J. James | S. Bhagwat | M. Gardner | Gabriel Pallares